N-acetyl-4-S-cysteaminylphenol

Known as: N-Ac-4-SCAP 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
The melanin biosynthetic pathway from tyrosine is a potential target for combating malignant melanoma. N-Acetyl-4-S… (More)
Is this relevant?
2005
2005
Interference with the biosynthetic pathway to melanin may be a useful means for developing new chemotherapeutic drugs to combat… (More)
Is this relevant?
2001
2001
N-Acetyl-4-S-cysteaminylphenol 1 is an analogue of a biosynthetic intermediate in the pathway to melanin. It is probably oxidized… (More)
Is this relevant?
2000
2000
N-Acetyl-4-S-cysteaminylphenol (1) has been shown by Jimbow and co-workers to possess useful antimelanoma activity. It is an… (More)
Is this relevant?
1998
1998
Chemotherapy of malignant melanoma is still a great challenge, as no effective drugs are available. The development of… (More)
Is this relevant?
1995
1995
This study examined the effect of glutathione on the in vivo depigmenting potency of N-acetyl-4-S-cysteaminylphenol (N-acetyl-4-S… (More)
Is this relevant?
1994
1994
In order to develop a new chemotherapeutic agent based on exploitation of the specific metabolic pathway of malignant melanoma, a… (More)
Is this relevant?
1992
1992
The rationale for melanoma-specific antitumor agents containing phenolic amines is based in part on the ability of the enzyme… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
1991
1991
BACKGROUND AND DESIGN --Melasma is a difficult medical problem to treat. Hydroquinone is administered to many patients, but it is… (More)
Is this relevant?
1991
1991
Previous in vivo studies have shown that 4-S-cysteaminylphenol (4-S-CAP) and N-acetyl-4-S-cysteaminylphenol (N-Ac-4-S-CAP) have… (More)
Is this relevant?